Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hepavax-B
- Development stage
- Unknown
- Lead developer
- Popular Pharmaceuticals
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Hepavax-B is a recombinant Hepatitis B vaccine designed for active immunization against all known subtypes of the Hepatitis B virus (HBV). It is manufactured by Popular Pharmaceuticals and is derived from the surface antigen of HBV, produced using genetically engineered yeast cells (Saccharomyces cerevisiae). The vaccine functions by stimulating the body's immune system to generate protective antibodies against the Hepatitis B surface antigen (HBsAg), thereby conferring immunity and preventing HBV infection. Additionally, it is expected to prevent Hepatitis D infection, which is contingent on the presence of Hepatitis B. Hepavax-B is administered via intramuscular injection.
- Brand names
- Hepavax-BHepavax B injectionHepavax-B Adult
- Other names
- Hepatitis B Vaccine (rDNA) BP
02
Targets
HBsAg (Hepatitis B surface antigen)
Beyond the preview
Go deeper on Hepavax-B.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hepavax-B.